{
    "title": "Biogen tabs veteran pharma leader Viehbacher as next CEO",
    "url": "https://www.dailymail.co.uk/wires/ap/article-11413253/Biogen-tabs-veteran-pharma-leader-Viehbacher-CEO.html",
    "date": "2022-11-10",
    "keywords": [
        "biogen",
        "sanofi",
        "viehbacher",
        "drug",
        "ceo",
        "launch",
        "treatment",
        "leader",
        "developer",
        "price",
        "company",
        "vounatsos",
        "program",
        "drugmaker",
        "file",
        "aduhelm",
        "cambridge",
        "inc",
        "thursday",
        "president",
        "monday",
        "successor",
        "announcement",
        "year",
        "coverage",
        "hesitancy",
        "spring",
        "spending",
        "revenue",
        "quarter",
        "part",
        "product",
        "portfolio",
        "sclerosis",
        "tecfidera",
        "spinraza",
        "disorder",
        "christopher",
        "thenceo",
        "press",
        "york",
        "ap",
        "photomark",
        "lennihan",
        "companys",
        "share",
        "takeover",
        "genzyme",
        "sanofis",
        "chairman",
        "board",
        "dissatisfaction",
        "management",
        "style",
        "handling",
        "business",
        "executive",
        "glaxosmithkline",
        "health",
        "care",
        "investment",
        "fund",
        "gurnet",
        "point",
        "capital",
        "morning",
        "tom",
        "murphy",
        "twitter",
        "thpmurphy",
        "headquarters",
        "march",
        "mass"
    ],
    "category": [
        "wires",
        "ap"
    ]
}